Light's effect on vision in age-related macular degeneration
Part of Eyes & vision clinical trials.
This study tests how different types of artificial lighting affect vision in people with dry age-related macular degeneration (AMD). It may help find ways to improve daily visual comfort and function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 60 years old.
- You have been diagnosed with dry AMD in both eyes.
- You have not had any eye surgery other than routine cataract removal, and that was at least 3 months ago.
- You do not have other eye diseases like glaucoma or diabetic retinopathy.
- You do not have serious health conditions that might affect your survival or participation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if repeated low-level red-light therapy can help people with dry age-related macular degeneration (AMD), a condition that causes gradual vision loss. The therapy uses red light to potentially slow or improve vision problems.
This trial tests whether visual rehabilitation can help improve both vision and mood in people with advanced dry age-related macular degeneration. It aims to understand the link between vision loss and depression.
This study observes how dry age-related macular degeneration (AMD) changes over time using regular eye exams. It may help doctors better understand the natural pattern of progression and which patients are more likely to worsen.
This study tests a light-based treatment (photobiomodulation) for dry AMD, using the Valeda Light Delivery System. It may help improve vision and eye health over time.
This study looks at how well the eyes function in people with early or intermediate age-related macular degeneration (AMD). It uses imaging and vision tests to help doctors better understand the condition.
This trial tests whether a special light treatment (photobiomodulation) can help people with dry age-related macular degeneration (AMD). It is designed for those with early to moderate dry AMD who still have fairly good vision.
Hear when a new AMD - Age-Related Macular Degeneration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.